#Aula introdutória, distribuição do plano de ensino e dos artigos (seminários).

#Seminário 1: Weigang Cui et al. Neuregulin 1 improved gastric motility and reduced gastric inflammation by activating the α7nAChR through the cholinergic anti-inflammatory pathway in diabetic rats. Toxicology and Applied Pharmacology, 495, 117205, 2025  (https://doi.org/10.1016/j.taap.2024.117205).

 #Seminário 2: Yu Tao et al. The role of alpha-7 nicotinic acetylcholine receptors in pain: potential therapeutic implications. Current Neuropharmacology, 23, 129-144, 2025 (10.2174/1570159X22666240528161117).   

#Seminário 3: Lingsheng Fu et al. M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study. Bioorg. Med. Chem., 105, 117728, 2024 (https://doi.org/10.1016/j.bmc.2024.117728)  

  #Seminário 4: Opeyemi Babatunde Ogunsuyi et al. Effect of curcumin–donepezil combination on spatial memory, astrocyte activation, and cholinesterase expressions in brain of scopolaminetreated rats. Molecular Biology Reports, 51:864, 2024 (https://doi.org/10.1007/s11033-024-09712-1).

#Seminário 5: Hannah C. Saternos et al. Muscarinic acetylcholine receptor 3 localized to primary endothelial cilia regulates blood pressure and cognition. Scientific Reports,  15:3745, 2025  (https://doi.org/10.1038/s41598-025-87212-3).

 #Seminário 6: Yoko IgarashiHisayoshi et al. Protective role of M3 muscarinic acetylcholine receptor in indomethacininduced small intestinal injury. Journal of Molecular Medicine, 102:1175–1186, 2024 (https://doi.org/10.1007/s00109-024-02474-0).